Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
20
Number of overlapping holdings
5.9%
% of FHLC's 368 holdings also in MEDX
66.7%
% of MEDX's 30 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.7% | 17.2% | 10.7% |
|
ABBVIE INC | 5.3% | 8.6% | 5.3% |
|
JOHNSON & JOHNSON | 5.9% | 4.7% | 4.7% |
|
MERCK & CO. INC. | 4.3% | 4.3% | 4.3% |
|
PFIZER INC | 2.5% | 4.4% | 2.5% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to MEDX
|
UNITEDHEALTH GROUP INC | 7.9% |
|
THERMO FISHER SCIENTIFIC INC | 3.4% |
|
ABBOTT LABORATORIES | 3.4% |
|
INTUITIVE SURGICAL INC | 3.2% |
|
DANAHER CORP | 2.5% |
|
BOSTON SCIENTIFIC CORP | 2.3% |
|
STRYKER CORP | 2.1% |
|
GILEAD SCIENCES INC | 2.0% |
|
VERTEX PHARMACEUTICALS INC | 1.8% |
 |
MEDTRONIC PLC | 1.7% |
FHLC Underweight Relative to MEDX
|
ELI LILLY & CO | -6.6% |
 |
NOVARTIS AG-ADR | -6.1% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.4% |
|
BRISTOL-MYERS SQUIBB CO | -4.4% |
|
ALKERMES PLC | -4.1% |
|
ALNYLAM PHARMACEUTICALS INC | -3.9% |
|
ABBVIE INC | -3.3% |
|
AMGEN INC | -3.3% |
|
CRISPR THERAPEUTICS AG | -2.6% |
|
BIOGEN IDEC INC | -2.6% |